Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic clinical trials, observational studies, and health surveys. In the context of RWE, patient recruitment plays a significant role, as the data collected from these individuals helps in understanding the effectiveness, safety, and usage of medical products in the real world.
Traditional Patient Recruitment: In traditional methods, patient recruitment generally happens through methods like physician referrals, media advertising, patient registries, and patient advocacy groups. This method can be time-consuming, costly, and sometimes inefficient, as it often relies on manual efforts. It can also be challenging to find patients who fit specific inclusion and exclusion criteria for a particular study.
AI-Enabled Recruitment: Artificial intelligence (AI) has started transforming patient recruitment in many ways. AI can analyze vast amounts of real-world data from electronic health records (EHRs), medical claims, health surveys, and other digital health platforms to identify eligible patients rapidly. This approach reduces the recruitment timeline and the costs associated with patient enrollment.
AI algorithms can predict the likelihood of patients participating in the study, improving the precision of recruitment. They can also monitor and analyze patient behavior, enabling the refinement of recruitment strategies in real-time. AI can further enhance the diversity of recruited patients by considering a wide range of demographic and geographic factors, leading to a more inclusive and representative study.
AI-enabled recruitment can also help in mitigating potential biases in patient selection by utilizing a data-driven approach. By analyzing historical clinical trial data, AI models can identify patterns and biases in previous studies and correct them in future ones. Furthermore, AI can help in patient retention by predicting the potential drop-out risks and enabling timely intervention.
In conclusion, while traditional methods are essential and remain relevant in certain contexts, AI-enabled recruitment offers the possibility of increased speed, reduced costs, and improved diversity and representativeness of patients in studies generating real-world evidence.
Share this story...
Real World Evidence (RWE) 101 – ‘Interventional’ Clinical Trial vs Non-Interventional Study
RWE 101 - 'Interventional' Clinical Trial vs Non-Interventional Study Interventional Clinical Trial: In this type of study, researchers actively intervene by assigning participants to different groups, administering specific treatments, [...]
Real World Evidence (RWE) 101 – Are the terms ‘clinical study’ and ‘clinical trial’ synonymous in the context of non-interventional studies?
RWE 101 - Are the terms 'clinical study' and 'clinical trial' synonymous in the context of non-interventional studies? No, "clinical study" and "clinical trial" are not necessarily synonymous in [...]
Real World Evidence (RWE) 101 – The Importance of Regulatory Definitions
RWE 101 - The Importance of Regulatory Definitions "Words are powerful"Regulatory definitions are important in the context of real-world evidence (RWE) studies and real-world research for several reasons:[1] Consistency: [...]
Real World Evidence (RWE) 101 – Regulatory Compliance
RWE 101 - Regulatory Compliance Regulatory compliance in the context of real-world evidence (RWE) refers to ensuring that the generation and use of RWE for regulatory purposes [...]
Real World Evidence (RWE) 101 – Regulatory Intelligence
RWE 101 - Regulatory Intelligence In the context of real-world evidence (RWE) and real-world research (RWR), regulatory intelligence refers to the process of gathering, analyzing, and interpreting regulatory information [...]
Real World Evidence (RWE) 101 – Regulatory Science
RWE 101 - Regulatory Science Regulatory science is a field of study that involves the application of scientific methods, principles, and data to the development and evaluation of regulatory [...]







